Lpl Financial LLC Halozyme Therapeutics, Inc. Transaction History

Lpl Financial LLC

$218 Billion
Q3 2024

A detailed history of Lpl Financial LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Lpl Financial LLC holds 151,593 shares of HALO stock, worth $7.21 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

151,593

Previous 114,831 32.01%

Holding current value

$7.21 Million

Previous $6.01 Million 44.24%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$51.3 - $64.42 $1.89 Million - $2.37 Million	36,762 Added 32.01%	151,593 $8.67 Million
Q2 2024 Aug 07, 2024	BUY	$37.81 - $52.4 $2.26 Million - $3.13 Million	59,701 Added 108.29%	114,831 $6.01 Million
Q1 2024 May 10, 2024	BUY	$33.68 - $41.95 $256,944 - $320,036	7,629 Added 16.06%	55,130 $2.24 Million
Q4 2023 Feb 14, 2024	BUY	$33.32 - $42.1 $145,974 - $184,440	4,381 Added 10.16%	47,501 $1.76 Million
Q3 2023 Nov 13, 2023	BUY	$36.46 - $44.03 $172,747 - $208,614	4,738 Added 12.34%	43,120 $1.65 Million
Q2 2023 Jul 31, 2023	BUY	$30.28 - $38.74 $245,691 - $314,336	8,114 Added 26.81%	38,382 $1.38 Million
Q1 2023 May 10, 2023	BUY	$32.86 - $55.7 $344,438 - $583,847	10,482 Added 52.98%	30,268 $1.16 Million
Q4 2022 Feb 07, 2023	BUY	$40.06 - $59.44 $196,454 - $291,493	4,904 Added 32.95%	19,786 $1.13 Million
Q3 2022 Nov 14, 2022	SELL	$38.53 - $51.78 $62,225 - $83,624	-1,615 Reduced 9.79%	14,882 $588,000
Q2 2022 Aug 12, 2022	BUY	$37.35 - $48.3 $76,231 - $98,580	2,041 Added 14.12%	16,497 $726,000
Q1 2022 May 16, 2022	SELL	$31.97 - $41.06 $323,952 - $416,060	-10,133 Reduced 41.21%	14,456 $577,000
Q4 2021 Feb 14, 2022	BUY	$31.82 - $40.75 $231,363 - $296,293	7,271 Added 41.99%	24,589 $989,000
Q3 2021 Nov 15, 2021	SELL	$38.47 - $46.42 $9,155 - $11,047	-238 Reduced 1.36%	17,318 $704,000
Q2 2021 Aug 13, 2021	BUY	$38.84 - $51.31 $80,787 - $106,724	2,080 Added 13.44%	17,556 $797,000
Q1 2021 May 14, 2021	BUY	$39.51 - $51.45 $197,154 - $256,735	4,990 Added 47.59%	15,476 $645,000
Q4 2020 Feb 12, 2021	BUY	$25.81 - $43.62 $12,492 - $21,112	484 Added 4.84%	10,486 $448,000
Q3 2020 Nov 09, 2020	SELL	$25.74 - $29.63 $712,328 - $819,980	-27,674 Reduced 73.45%	10,002 $263,000
Q2 2020 Aug 13, 2020	BUY	$16.25 - $26.81 $612,235 - $1.01 Million	37,676 New	37,676 $1.01 Million

Others Institutions Holding HALO

# of Institutions

543

Shares Held

125M

Call Options Held

294K

Put Options Held

180K

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.62B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Account

Lpl Financial LLC Halozyme Therapeutics, Inc. Transaction History